[1] 许承弼, 滕博, 李长青, 金春顺, XU Cheng-bi, TENG Bo, LI Chang-qing, JIN Chun-shun. 喉鳞状细胞癌中RASSF1A基因启动子区甲基化及蛋白表达 [J]. 吉林大学学报（医学版） 2006.doi:10.3969/j.issn.1671-587X.2006.02.043
[2] 丛德刚, 王胜发, 张铁娃, CONG De-gang, WANG Sheng-fa, ZHANG Tie-wa. RASSF1A基因在食管癌组织中的表达及其临床意义 [J]. 中华医学杂志 2006.doi:10.3760/j:issn:0376-2491.2006.23.010
[3] Parkin D M. Global cancer statistics in the year 2000 [J]. LANCET ONCOLOGY 2001, 2(09).
[4] Hamiliond W, Lusher M E, Lindsey J C. Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma [J]. Cancer 2005, 227(01).
[5] Hesson L B, Cooper W N, Latif F. The role of RASSF1A bypermethylation in cancer [J]. Disease Markers 2007, 23(1-2).
[6] Katoh M. WNT and FGF gene clusters (Review). [J]. International journal of oncology 2002, 6(6).
[7] Nakashima H, Mori M, Mimori K. Microsatellite in stability in Japanese ESCC [J]. International Journal of Cancer 1995, 64(04).
[8] Min Sup Song, Su Jeong Song, Nagi G. Ayad, Jin Sook Chang, Joo Hyun Lee, Hyun Kyung Hong, Ho Lee, Naeyun Choi, Jhingook Kim, Hojoong Kim. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex [J]. Nature cell biology 2004, 2(2).
[9] Zhang N, Chen P, Khanna K K. Isolation of full length ATMc DNA and correction of the ataxia telangiectasia cell ular phenotype [J]. Proceedings of the National Academy of Sciences(USA) 1997, 94(15).
[10] Ngan E S, Ma Z Q, Chua S S. Inducible expression of FGF-3 in mouse mammary gland [J]. Proceedings of the National Academy of Sciences(USA) 2002, 99(12).
[11] Galdemard C, Yamagata H, Brison O, Lavialle C. [J]. The Journal of biological chemistry 2000.
[12] Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. [J]. Trends in molecular medicine 2002, 10(10).
[13] Hajitou A, Baramova E N, Bajou K. FGF2 3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells [J]. Oncogene 1998, 17(16). |
